83bar Announces New Investment from HealthQuest Capital
AUSTIN, Texas, July 26, 2021 /PRNewswire/ -- 83bar, Inc., a specialist in patient journey management and developer of patient activation technology that has successfully supported nearly one hundred pharma, diagnostic and medtech development programs, has achieved a new milestone after a five-year period of start-up growth with a major capital infusion to fuel the next phase of its impact in the medical marketing services industry, as well as in the $60 billion clinical trials sector.
HealthQuest Capital, a healthcare-focused venture growth fund that invests in and accelerates innovative, commercial-stage companies, has made an equity investment in 83bar, according to a joint announcement from Robert Baurys, CEO at 83bar and Anthony Williams, Partner at HealthQuest.
The transaction includes the equity investment from HealthQuest, as well as a $20 million debt facility from MidCap Financial Trust. Terms of the investment were not disclosed.